Belinostat (Beleodaq) - Oncology Nurse Advisor

Belinostat (Beleodaq)

Slideshow

  • Slide

  • Slide

  • Slide

  • You can skip this ad in 3 seconds.
  • Slide

  • Slide

  • Slide

  • You can skip this ad in 3 seconds.
  • Slide

  • Slide

  • Slide

  • You can skip this ad in 3 seconds.
  • Slide

  • Slide

  • Slide

  • You can skip this ad in 3 seconds.
  • Slide

  • Slide

  • Slide

  • You can skip this ad in 3 seconds.
  • Slide

  • Slide

  • Slide

  • You can skip this ad in 3 seconds.
  • Slide

  • Slide

  • Slide

  • You can skip this ad in 3 seconds.
  • Slide

  • Slide

  • Slide

This slideshow reviews belinostat (Beleodaq), indicated for relapsed or refractory peripheral T-cell lymphoma (PTCL).

Table of Contents

Slide 4: Dosage and Administration
Slide 12: Cautions, Effects, and Interactions
Slide 18: What to Tell Your Patient
Slide 24: Reference 

Next hm-slideshow in Slides